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INTRODUCTION: The increasing number of multidrug-resistant Pseudomonas aeruginosa 
worldwide need to be continuously monitored to prevent its transmission. This study reviewed 
multidrug-resistant Pseudomonas aeruginosa in Southeast Asia.  
METHODS: Pubmed database was searched (January 2013-March 2018) for relevant articles 
using specific names of all eleven Southeast Asian countries. The articles retrieved were screened 
and analyzed to meet the inclusion criteria.  
RESULTS: A total of 17 articles met the inclusion criteria. Vietnam had the most published data 
included in this study, East Timor, Cambodia, and Laos had none. There are variations among 
Pseudomonas aeruginosa resistance in Southeast Asia. Thailand had complete data on antibiotic 
resistance and had the highest resistance rate of almost all antibiotics. Colistin had the lowest 
resistance rate among all antibiotics.  
CONCLUSIONS: Colistin had the lowest resistance rate among all antibiotics. Another study 
with more extensive data should be done to validate this study. Future research should be 
explicitly providing detail data results for antimicrobial resistance analyses.  
Keyword: Pseudomonas aeruginosa, antimicrobial resistance, Southeast Asia 
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INTRODUCTION 
Healthcare-associated infections (HAIs) or previously known as nosocomial infections are an 
infection that happens within 48 hours after admission in a health care facility. In surgery, the 
timing can extend up to 30 days (Haque et al., 2018). Surgical site infection (SSI), ventilator-
associated pneumonia (VAP), catheter-associated urinary tract infection (CAUTI), and central 
line-associated bloodstream infection (CLABSI) are examples of HAIs (Al-Tawfiq and Tambyah, 
2014). HAIs is major problem due to its high morbidity, mortality, and healthcare cost. The case 
fatality rate (CFR) for SSI, VAP, CAUTI, and CLABSI are 2.8%, 14.4%, 2.3%, and 12.3%, 
respectively (Al-Tawfiq and Tambyah, 2014). Most HAIs are caused by multi-drug resistance 
organisms (MDRO) (Haque et al., 2018). Pseudomonas aeruginosa is one of the most common 
MDRO that can cause HAIs (Nathwani et al., 2014, Treepong et al., 2018).  
Infectious Diseases Society of America (IDSA) even classify P. aeruginosa along with 
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumanii, and 
Enterobacter species as the “ESKAPE” pathogen (Boucher et al., Khuntayaporn et al., 2013). Those 
bacteria can easily “escape” from antibiotic treatment, and the presence of intrinsic resistance and 
acquisition of resistance genes results in fewer treatment options for P. aeruginosa infection 
(Treepong et al., 2018, Boucher et al.). The increasing number of multidrug-resistant P. aeruginosa 
outbreaks that affected patients’ life and numerous healthcare facilities in the last few decades 
deserves our attention (Wieland et al., 2018). The authors are interested in doing a literature 
review related to P. aeruginosa because there is no recent review pertaining to P. aeruginosa 




This research was a systematic review conducted by using the PubMed database as a search 
engine. The keywords used in the search include "Pseudomonas aeruginosa", "Southeast Asia", 
"Resistance", and specific names of all eleven Southeast Asia countries (“Indonesia”, 
“Singapore”, “Thailand”, “Vietnam”, “Malaysia”, “Philippines”, “Myanmar” or “ Burma”, 
“Brunei” or “Brunei Darussalam”, “Timor Leste” or “East Timor”,” Cambodia”, “Laos” or “Lao 
PDR” or “Lao People’s Democratic Republic”). Filters activated were publications from January 
2013 to March 2018, full text available, species found in humans. 
 
Selection criteria and article quality assessment 
Inclusion criteria were articles written in English or Indonesian. The articles retrieved were 
screened by abstract reading by author and co-author independently. Any discrepancy found was 
being discussed. Scoring systems are used to assess article quality: valid and reliable identification 
methods, such as using Phoenix® (Becton Dickinson), Vitek® (bioMérieux), internationally 
standardized biochemical test, molecular (0 = no, 1 = yes); antibiotic susceptibility testing (AST) 
using an internationally standardized system, e.g., Clinical & Laboratory Standards Institute 
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(CLSI)  (0 = no, 1 = yes). Only articles value 2 were analyzed further. Data representing a mix of 
strains from several countries were excluded. 
 
Data analysis 
Data extracted included article information (first author’s name, year of publication), study design  
(location, source of data, source of infection, type of infection, age group, antibacterial resistance), 
identification and AST method used. Data were analyzed using IBM® SPSS® Statistic 24. (SPSS, 




Our search identified 91 articles. Of this, 36 were excluded due to duplication and inaccessible full 
text, 36 more were excluded during abstract screening, and two articles excluded because 

























Full-text article excluded: 
 a mix of strains from 







Records identified by Pubmed search (n=91) 
 
“Southeast asia”=24, “Singapore”=21, “Thailand”=18, “Vietnam”=12, 
“Malaysia”=10, “Philippines”=4 “Indonesia”=1, “Myanmar”=1, 
“Brunei” or “Brunei Darussalam”, “Timor Leste” or “East Timor”=0, 













Of the 17 articles included, 2013 was the year that has the most publications (Table 1). Vietnam 
and Thailand had most of the data (59%), Singapore, Malaysia, and Indonesia accounting for 
35%, and there was one multinational study. Most of the articles had cross-sectional as their study 
design. Isolates were most commonly cultured from hospital-acquired infections of persons of all 
ages than solely from children or adults.  
 
Laboratory methods 
Method for identification used in the study from the highest number, respectively, were 
molecular, MALDI-TOF, API, and biochemically (Table 1). Disk diffusion was the most 
common method for AST used. Several studies did not mention their method of identification. 
They were a multicentre study that had followed the PPS methodology developed by ECDC and 
a review study. A study that did not mention their AST method was also a multicentre study and 
a molecular-based study. The multicentre study was following criteria from the Clinical and 
Laboratory Standards Institute guidelines (CLSI) and was enrolled in an external quality 
assurance program for microbiology.  
 
Table 1. Characteristic of the articles included 
Characteristic Frequency  
N  (%) 
References 
Publication Year   
2013 7  (41.2) (Apisarnthanarak et al., 2013, 
Karuniawati et al., 2013, 
Khuntayaporn et al., 2013, 
Kiddee et al., 2013, Kor et al., 
2013, Lim et al., 2013a, Tada 
et al., 2013) 
2014 2  (11.8) (Biedenbach et al., 2014, 
Cheng et al., 2014) 
2015 2  (11.8) (Teo et al., 2015, Wong et al., 
2015) 
2016 5  (29.4) (Biedenbach et al., 2016, 
Kazmierczak et al., 2016, Le et 
al., 2016, Phu et al., 2016, 
Tada et al., 2016) 
2017 1  (5.9) (Tran et al., 2017) 
Country   
Indonesia 1  (5.9) (Karuniawati et al., 2013) 
Malaysia 2  (11.8) (Kor et al., 2013, Wong et al., 
2015) 
Singapore 3  (17.6) (Lim et al., 2013a, Cheng et al., 
2014, Teo et al., 2015) 
Thailand 3  (17.6) (Khuntayaporn et al., 2013, 
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Characteristic Frequency  
N  (%) 
References 
Kiddee et al., 2013, 
Apisarnthanarak et al., 2013) 
Vietnam 7  (41.2) (Tada et al., 2013, Biedenbach 
et al., 2014, Biedenbach et al., 
2016, Le et al., 2016, Phu et al., 
2016, Tada et al., 2016, Tran et 
al., 2017) 
Multinational 1  (5.9) (Kazmierczak et al., 2016) 
Study Design   
Cross sectional/ Case Series 10  (58.8) (Karuniawati et al., 2013, Kor 
et al., 2013, Wong et al., 2015, 
Teo et al., 2015, Khuntayaporn 
et al., 2013, Kiddee et al., 2013, 
Biedenbach et al., 2014, 
Biedenbach et al., 2016, Tada 
et al., 2016, Tran et al., 2017) 
Retrospective 3  (17.6) (Lim et al., 2013a, Cheng et al., 
2014, Tada et al., 2013) 
Surveillance 3  (17.6) (Phu et al., 2016, Le et al., 
2016, Kazmierczak et al., 
2016) 
Review 1  (5.9) (Apisarnthanarak et al., 2013) 
Age    
0-18 1  (5.9) (Le et al., 2016) 
>18 4  (23.5) (Teo et al., 2015, Tran et al., 
2017, Lim et al., 2013a, Phu et 
al., 2016) 
All ages 12  (70.6) (Karuniawati et al., 2013, Kor 
et al., 2013, Wong et al., 2015, 
Khuntayaporn et al., 2013, 
Kiddee et al., 2013, 
Biedenbach et al., 2014, 
Biedenbach et al., 2016, Tada 
et al., 2016, Cheng et al., 2014, 
Tada et al., 2013, Kazmierczak 
et al., 2016, Apisarnthanarak et 
al., 2013) 
Type of Infection   
Hospital-acquired 14  (82.3) (Karuniawati et al., 2013, Kor 
et al., 2013, Teo et al., 2015, 
Khuntayaporn et al., 2013, 
Kiddee et al., 2013, 
Biedenbach et al., 2014, 
Biedenbach et al., 2016, Tada 
et al., 2016, Tran et al., 2017, 
Lim et al., 2013a, Cheng et al., 
2014, Tada et al., 2013, Le et 
al., 2016, Phu et al., 2016) 
Unknown 3  (17.6) (Wong et al., 2015, 
Kazmierczak et al., 2016, 
Apisarnthanarak et al., 2013) 
Method for Identification   
MALDI-TOF  2  (11.8) (Biedenbach et al., 2016, 
Kazmierczak et al., 2016) 
API system  (bioMérieux) 2  (11.8) (Wong et al., 2015, Kor et al., 
2013) 
Biochemical 1  (5.9) (Tran et al., 2017) 
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Characteristic Frequency  
N  (%) 
References 
Molecular, PCR 8  (47.0) (Karuniawati et al., 2013, Teo 
et al., 2015, Khuntayaporn et 
al., 2013, Kiddee et al., 2013, 
Biedenbach et al., 2014, Tada 
et al., 2016, Cheng et al., 2014, 
Tada et al., 2013) 
Not mentioned 4  (23.5) (Lim et al., 2013b, Le et al., 
2016, Phu et al., 2016, 
Apisarnthanarak et al., 2013) 
Method for AST   
Disk diffusion 5  (29.4) (Karuniawati et al., 2013, Kor 
et al., 2013, Khuntayaporn et 
al., 2013, Kiddee et al., 2013, 
Tran et al., 2017) 
Semi automatic 2  (11.8) (Wong et al., 2015, 
Biedenbach et al., 2014) 
Broth microdilution 4  (23.5) (Biedenbach et al., 2016, Tada 
et al., 2016, Tada et al., 2013, 
Kazmierczak et al., 2016) 
Not mentioned 5  (29.4) (Teo et al., 2015, Lim et al., 
2013a, Le et al., 2016, Phu et 
al., 2016, Apisarnthanarak et 
al., 2013) 
Not performed 1  (5.9) (Cheng et al., 2014) 
 
Resistance rate 
There were only Vietnam, Thailand, Indonesia, Singapore, and Malaysia that can be analyzed in 
this study regarding the resistance rate to different classes of antibiotics (Table 2). There were four 
studies from Vietnam, two studies from Thailand, and only one study from Malaysia, Singapore, 
and Indonesia. This study calculated all the isolates numbers found in the articles into one 
specimen size for each country to be used as a numerator. Vietnam had the biggest isolates 
numbers, and others had less than 100 isolates. There was no specimen size found in the 
Indonesian study. 
There was a variable P. aeruginosa resistance rate among countries for different classes of 
antibiotics. Thailand had the complete data of antibiotic resistance and had the highest resistance 
rate of almost all antibiotics listed (Table 2), except for carbapenem. Overall, Singapore had the 
highest resistance to carbapenem. But, if we look at individual data, one study from Vietnam had 
a 71% resistance rate on carbapenem (Le et al., 2016). Colistin had the lowest resistance rate 
among all antibiotics. 
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 614 50 a 55 84 
Ceftazidime 42.9 88 - - 2.4 
Cefotaxime - 100 - - - 
Ceftriaxone 4.72 100 - - - 
Cefepime 32.7 96 - - 4.8 
Piperacillin - 70 - - - 
Piperacillin-tazobactam 13.5 20 - - 7.1 
Ticarcillin - 88 - - - 
Ticarcillin/clavulanate
 - 98 - - 8.3 
Cefoperazone - 94 - - - 
Cefoperazone/sulbactam 2.9 - - - - 
Carbapenem 3.9 14.4-15.5a 21.9 50 - 
Imipenem 41.5 92 - - - 
Meropenem 37.1 100 - - 3.6 
Doripenem 30.1 - - - - 
Aztreonam - 90 - - 8.3 
Ciprofloxacin 40.5 90 - - 4.8 
Ofloxacin - 92 - - - 
Levofloxacin 41.3 92 - - - 
Gentamicin 39.7 82 - - 4.8 
Tobramycin 35.8 - - - 4.8 
Amikacin 18.24 62 - - 2.4 
Colistin 0.1 0 - - - 
a Specimen size unknown 
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Table 3. Genetic analysis 
Resistance genes Country of isolation Isolate number Reference 
β-lactamase    
blaIMP-1 Indonesia 4 (Karuniawati et al., 
2013) 
 Malaysia 1 (Kazmierczak et al., 
2016) 
 Phillipines 1 (Kazmierczak et al., 
2016) 
 Thailand 2 (Kazmierczak et al., 
2016) 
blaIMP-7 Thailand 1 (Kazmierczak et al., 
2016) 
blaIMP-14 Thailand 1 (Kazmierczak et al., 
2016) 
blaIMP-15 Vietnam 10 (Tada et al., 2016) 
blaIMP-26 Vietnam 12 (Tada et al., 2016)  
 Phillipines 10 (Kazmierczak et al., 
2016) 
blaIMP-48 Thailand 6 (Kazmierczak et al., 
2016) 
blaIMP-51 Vietnam 3 (Tada et al., 2016) 
blaVIM-2 Phillipines 21 (Kazmierczak et al., 
2016) 
 Thailand 3 (Kazmierczak et al., 
2016) 
blaVIM-5 Thailand 2 (Kazmierczak et al., 
2016) 
blaVIM-6 Malaysia 1 (Kazmierczak et al., 
2016) 
blaVIM-45 Thailand 2 (Kazmierczak et al., 
2016) 
blaVEB-1 Vietnam 5 (Tada et al., 2016) 
 Singapore 3 (Cheng et al., 2014) 
blaVEB-2 Thailand 1 (Kiddee et al., 2013) 
blaNDM-1 Vietnam 1 (Tada et al., 2016) 
 Phillipines 13 (Kazmierczak et al., 
2016) 
 Thailand 4 (Kazmierczak et al., 
2016) 
 Singapore 3 (Teo et al., 2015) 
blaOXA-10 Thailand 1 (Kiddee et al., 2013) 
blaPER-1 Vietnam 2 (Tada et al., 2016) 
blaPSE-1 Vietnam 12 (Tada et al., 2016) 
 Thailand 2 (Kiddee et al., 2013) 




Thailand 5 (Khuntayaporn et al., 
2013) 
    
Aminoglycoside     
aac  (3”)-Ia Vietnam 7 (Tada et al., 2016) 
aac  (3)-Ic Thailand  10 (Kiddee et al., 2013) 
aac  (6’)-Ib Vietnam 20 (Tada et al., 2016) 
 Thailand 5  
aacA4 Malaysia 1 (Kor et al., 2013) 
aacA7 Thailand  10 (Kiddee et al., 2013) 
aacA37 Vietnam 12 (Tada et al., 2016) 
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aacC3 Malaysia 5 (Kor et al., 2013) 
aadA1 Vietnam 7 (Tada et al., 2016) 
 Thailand 1 (Kiddee et al., 2013)  
 Malaysia 1 (Kor et al., 2013) 
aadA2 Thailand 2 (Kiddee et al., 2013)  
aadA6 Thailand 25 (Kiddee et al., 2013)  
 Malaysia 8 (Kor et al., 2013) 
aadA11 Vietnam 27 (Tada et al., 2016) 
aadA15 Thailand 1 (Kiddee et al., 2013)  
aadB Vietnam 6 (Tada et al., 2016) 
 Thailand 9 (Kiddee et al., 2013) 
aph  (3’)-Via Vietnam 2 (Tada et al., 2016) 
Arr Thailand 1 (Kiddee et al., 2013)  
cmlA5 Thailand 11 (Kiddee et al., 2013)  
 Malaysia 5 (Kor et al., 2013) 
cmlA6 Thailand 1 (Kiddee et al., 2013)  
orfD Thailand 25 (Kiddee et al., 2013)  
 Malaysia 8 (Kor et al., 2013) 
rmtB Vietnam 13 (Tada et al., 2016) 
  2 (Tada et al., 2013) 
Smr Thailand 10 (Kiddee et al., 2013)  
tnpA Thailand 1 (Kiddee et al., 2013)  
 
Genetic Analysis 
Reports from Malaysia and Thailand showed the possibility of drug-resistant Pseudomonas 
aeruginosa harboring integron spreading (Kor et al., 2013, Kiddee et al., 2013). Integrons are mostly 
located on transposon, with class 1 integrons are the most commonly found in antibiotic-resistant 
Pseudomonas aeruginosa (Kiddee et al., 2013, Kor et al., 2013) Sequence analysis from class 1 
integron in Northern Thailand revealed resistance to aminoglycoside (aac, aad and aph), 
chloramphenicol  (cmlA), β-lactams  (blaPSE, blaOXA and blaVEB) and rifampicin  (arr) (Kiddee et al., 
2013) Study in Malaysia also found class 2 integrons from MDR Pseudomonas aeruginosa, although 
in small number of isolate, and the most common gene cassettes were those encoding resistance to 
trimethoprim  (dfr), and aminoglycosides  (aad) (Kor et al., 2013) 
 
DISCUSSION 
In this study, we found that in Southeast Asia, most P.aeruginosa was still sensitive to 
colistin. A similar result was found in Germany; from ten year period, researchers found that both 
MDR and non-MDR P.aeruginosa was still susceptible to colistin (Yayan et al., 2015). 
Our study shows that P.aeruginosa resistance to antibiotic were endemic in almost all 
antibiotics. Class A ESBLs deliver resistance to expanded-spectrum cephalosporins and are 
inhibited in vitro by β-lactamase combination agents (Potron et al., 2015) Two isolates of blaPER-
1, the first ESBL identified, was found in Vietnam (Tada et al., 2016)  
Class B β-lactamases hydrolyze carbapenems and other-lactams and not inhibited in vitro 
by β-lactamase combination agents (Potron et al., 2015) Resistance to carbapenems in P.aeruginosa 
is caused by reduced antibiotic permeability, includes a nontransmissible porin deficiency  
(reduction of OprD protein expression), efflux pump; and modification of antibiotics by 
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overproducing β-lactamases (AmpC cephalosporinase) and metallo-β-lactamases  (primarily IMP 
and VIM) (Apisarnthanarak et al., 2013, Khuntayaporn et al., 2013) Reduction in oprD 
transcription, mexAB-oprM mRNA overproduction and mexXY mRNA overproduction are the 
most prevalent resistance mechanisms, whereas AmpC overexpression is the least prevalent 
among Thailand carbapenem resistant P. aeruginosa clinical isolates (Khuntayaporn et al., 2013) In 
Southeast Asia, most carbapenemases-producer P.aeruginosa harbor blaIMP and blaVIM gene 
(Karuniawati et al., 2013) (Kazmierczak et al., 2016) Three case of blaNDM-1 producer P.aeruginosa 
has been found in surgical intensive care unit in Singapore, suggested a transmission event (Teo et 
al., 2015)  
The resistance mechanism of Pseudomonas aeruginosa to aminoglycoside are due to 
enzymatic modification and the methylation of 16S rRNA. Eight plasmid-associated 16sRNA 
methylase genes are armA, rmtA, rmtB, rmtC, rmtD, rmtE, rmtF and npmA. rmtB was found in 
hospitals in Vietnam (Tada et al., 2013). Resistance P. aeruginosa to colistin remains unclear, with 
the linkage between genes PmrAB, PhoPQ, ParRS and CprRS (Bialvaei and Samadi Kafil, 2015). 
We only used PubMed as a search engine, and that limits our data. We suggest further 
study using various search engine that is readily accessible to extend the number of the included 
articles. Experiencing difficulties in gathering the data, we also suggest researchers focusing on 
antimicrobial resistance to explicitly provide detail data both in the method and result section. 
 
CONCLUSIONS 
Colistin had the lowest resistance rate among all antibiotics. Another study with more extensive 
data should be done to validate this study. Future research should explicitly provide detail data 
results for antimicrobial resistance analyses.  
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